Navigation Links
Gulfport-Biloxi Airport Welcomes Installation of New YoNaturals Healthy Vending Machines
Date:5/2/2008

SAN DIEGO, May 2 /PRNewswire/ -- With an aggressive growth plan in effect for 2008, YoNaturals Inc., the nations leading healthy vending provider, has taken another big step in their expansion efforts with new vending locations in the state of Mississippi.

Established in August of 2006, YoNaturals has maintained a strong dedication toward changing the way consumers snack. The success and fast growth they have experienced thus far is in large part due to their dynamic business model, which is centered around the incorporation of three of today's incessant consumer trends; convenience, health, and organics. Mark Trotter, CEO of YoNaturals, explains that, "People are demanding healthier snake options for themselves in the workplace and at their local health clubs, and even more importantly, for their children in schools."

As interest in YoNaturals' products and services continue to gain momentum across the U.S., the most recent to take action and establish healthy vending locations include; the Gulfport-Biloxi International Airport, and various other spots across the state of Mississippi. The airport, an obvious high- traffic area, and statewide landmark, will now be offering its guests an assortment of healthy snacking options through YoNaturals' vending machines. The Edgewater Mall, Ocean Springs High School, Gulf Coast Research Laboratory, and Ocean Springs YMCA will also be providing its customers and students with snacks and beverages from YoNaturals' natural and organic line-up.

Also, YoNaturals has sought out the expertise of a top nutritionist Dr. Roy Vartabedian author of New York Times best seller Nutripoints to put together a product line-up that meets the highest degree of nutritional guidelines. YoNaturals state of the art vending machine with wireless remote monitoring capabilities designed with ultimate convenience in mind, for both consumers and owners, is the final piece that allows this model to work with complete synergy.
'/>"/>

SOURCE YoNaturals Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Akron-Canton Airport offering flu shot clinic for 90 days
2. New T-ray Source Could Improve Airport Security, Cancer Detection
3. Philly International Airport Tops AXEs Best and Worst Airports to Make a Connection
4. IDC Awarded Digital Radiography Contract With Beijing Capital Airport
5. Womens World Banking Welcomes New Network Member From Tunisia
6. MJGC Welcomes New Administrator-in-Training Shlomo Katz
7. MJGC Welcomes New Director of Social Work Alla Lerner
8. Patient Advocate Foundation Welcomes Leading Health Care Experts to Executive Board of Directors
9. Friends of WFP Welcomes World Hunger Relief Week
10. New York City Aesthetic Plastic Surgeon Welcomes top Skin Care Line into his Office
11. St. Pauls Senior Homes & Services Welcomes Some of San Diegos Neediest Displaced Seniors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... (May 22, 2012) Scientists at Virginia Commonwealth ... closer to developing a new therapy for acute ... agents obatoclax and sorafenib kill leukemia cells much ... are administered individually., Recently published in the journal ... Steven Grant, M.D., Shirley Carter Olsson and Sture ...
(Date:5/22/2012)... 2012) Pushed to the brink of survival, the ... ancient system that has helped organisms cope with internal ... an integral part of this system, heat shock protein ... accommodate the genetic changes and profound disturbances in normal ... theorized that inhibiting HSP90 just might render breast cancer ...
(Date:5/22/2012)... PORTLAND, Ore. Women who are unable to ... lung function of their newborns by taking Vitamin ... Oregon Health & Science University Doernbecher Children,s Hospital. ... affect the lung development of the developing baby, ... risk of asthma," said Cindy McEvoy, M.D., M.C.R., ...
(Date:5/22/2012)... May 22 (HealthDay News) -- The number of liver ... a new study finds. Researchers said one reason ... death has become more commonplace, and many of those ... organs aren,t healthy enough to attempt a transplant. Another ... to a condition known as fatty liver disease, which ...
(Date:5/22/2012)... microfluidic chip to test for latent tuberculosis. They hope ... than current testing for the disease. , "Our assay ... said Ying Liu, a research specialist working with Professor ... Engineering. , The team has already conducted testing of ... States. , About one-third of the world,s population is ...
Breaking Medicine News(10 mins):Health News:VCU Massey Cancer Center sees potential in novel leukemia treatment 2Health News:VCU Massey Cancer Center sees potential in novel leukemia treatment 3Health News:Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy 2Health News:Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy 3Health News:Vitamin C improves lung function in newborns of pregnant smoking women 2Health News:U.S. Liver Transplants Declining 2Health News:New TB test promises to be cheap and fast 2
... Researchers in Germany have developed a new risk assessment ... and patient's risk of cardiac death. , ECG is ... death can be determined and analysed by the computer.The ... to be calculated.// When the programme has completed its ...
... Researchers in France say that the distorting spectacles can ... balance. They think that the spectacles reset the patient's ... to a long-lasitng cure for some postural problems. ... hemisphere may suffer paralysis down their left side and ...
... of starch, previously thought to be just 'empty calories', actually ... Research Organisation (CSIRO), researchers have revealed that resistant starch could ... cancer. , , ... and China have low rates of bowel cancer even though ...
... has now been developed, which makes the process of providing ... , , The device, called Percutaneous ... involves giving artificial respiration to critically ill patients.// , ... the wall of the trachea,the passage leading to the lungs, ...
... is linked with deliquent behaviour of the chilren later ... Delaney-Black, of Children's Hospital of Michigan, the co author ... in comparison to the teetotallers ,women who drank the ... three times more likely to have a child diagnosed ...
... by the National Institutes of Health, showed that at-risk ... reduced their risk of diabetes by 58%, even without ... type 2 diabetes can sharply reduce the odds through ... data from the nation's first major clinical trial to ...
Other Medicine News:
(Date:5/22/2012)... -- Comprehensive Care Corporation ("CompCare") (OTC BB: CHCR), a ... management services provider for managed care companies throughout ... the first quarter of 2012 ending March 31, ... the quarter. "We are pleased ... modest, for its first quarter of 2012.  This ...
(Date:5/22/2012)... May 22, 2012  Based on its recent ... Sullivan recognizes Labcyte Inc. with the 2012 North ... liquid handler. While various liquid handling technologies provide ... range of advantages provided by the Echo liquid ... handling, Labcyte developed a platform enabling assay miniaturization ...
(Date:5/22/2012)... GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), an Atlanta-based biopharmaceutical ... Immunodeficiency Virus (HIV) infections, today announced that the ... enrollment for a Phase 1 trial for the ... identical to the first generation (currently ... the inclusion of granulocyte-macrophage colony-stimulating factor (GM-CSF) as ...
Breaking Medicine Technology:Comprehensive Care Corporation Announces Profit for First Quarter 2Comprehensive Care Corporation Announces Profit for First Quarter 3Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market 2Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market 3Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market 4Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market 5HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 2HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 3HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 4 Some Folks Just Cant Help Being Nice Study Suggests 90172 1 Some Folks Just Cant Help Being Nice Study Suggests 90172 2Power without the cord 90168 1Power without the cord 90168 2Power without the cord 90168 3AFAR announces the 2012 Hartford Centers of Excellence in Geriatric Medicine awards 90164 1AFAR announces the 2012 Hartford Centers of Excellence in Geriatric Medicine awards 90164 2
... 12 Lixte,Biotechnology Holdings, Inc. (OTC Bulletin Board: ... application for the use of compounds the company,is ... treatments for,neurodegenerative diseases including Alzheimer,s and Parkinson,s Disease., ... of Lixte, said, "Lixte has,developed a series of ...
... Neurobiological,Technologies, Inc. (NTI(R)) (Nasdaq: NTII ) ... pivotal studies evaluating Viprinex(TM) (ancrod) for,the treatment of ... patients,necessary to conduct a planned interim analysis across ... is safe and effective for treating,acute ischemic stroke ...
Other Medicine Technology:Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases 2Neurobiological Technologies Reaches Patient Enrollment Target For Interim Analysis of Viprinex(TM) Phase 3 Stroke Trials 2Neurobiological Technologies Reaches Patient Enrollment Target For Interim Analysis of Viprinex(TM) Phase 3 Stroke Trials 3
Angled 30 degree shaft. 13 mm from tip to bend with 2.5 mm hook curved tip. Polished finished. Overall length excluding hub: 35 mm, 1.4 inches....
Binkhorst, length 18 mm....
Army/Navy retractor (set of 2)....
Sharp. 4 mm wide. Hand-Held...
Medicine Products: